Last updated on February 2018

Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Primary Amyloidosis | Amyloidosis
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients with AL amyloidosis at Tufts Medical Center who have baseline bone marrow samples available and achieve a CR or VGPR to treatment. Patients may consent and register at diagnosis and have a baseline marrow collected at the time of consent; or patients may consent during therapy prior to achieving a response, if they have previously banked marrow cells for research.

Exclusion Criteria:

  • Patients who do not have available baseline bone marrow samples.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.